NASDAQ:OBSV - Obseva Stock Price, Forecast & News

Obseva trades on the NASDAQ under the ticker symbol "OBSV."

Obseva SA (NASDAQ:OBSV) issued its quarterly earnings data on Thursday, November, 7th. The company reported ($0.63) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($0.82) by $0.19. View Obseva's Earnings History.

Obseva is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Obseva.

Obseva will be holding an earnings conference call on Thursday, March 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

4 Wall Street analysts have issued 1-year price objectives for Obseva's shares. Their forecasts range from $4.00 to $40.00. On average, they expect Obseva's share price to reach $24.75 in the next year. This suggests a possible upside of 716.8% from the stock's current price. View Analyst Price Targets for Obseva.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Obseva in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Obseva.

Press coverage about OBSV stock has been trending very negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Obseva earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term. View News Stories for Obseva.

Obseva saw a increase in short interest in the month of February. As of February 14th, there was short interest totalling 1,470,000 shares, an increase of 33.6% from the January 30th total of 1,100,000 shares. Based on an average daily volume of 1,070,000 shares, the days-to-cover ratio is currently 1.4 days. Approximately 7.2% of the company's shares are short sold. View Obseva's Current Options Chain.

Some companies that are related to Obseva include Emisphere Technologies (EMIS), Kura Oncology (KURA), RAPT Therapeutics (RAPT), XBiotech (XBIT), Crinetics Pharmaceuticals (CRNX), AC Immune (ACIU), Neoleukin Therapeutics (NLTX), Milestone Pharmaceuticals (MIST), Morphic (MORF), 89bio (ETNB), Assembly Biosciences (ASMB), Sinovac Biotech (SVA), TherapeuticsMD (TXMD), CytoDyn (CYDY) and Satsuma Pharmaceuticals (STSA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Obseva investors own include Allena Pharmaceuticals (ALNA), Viking Therapeutics (VKTX), Amicus Therapeutics (FOLD), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD), Progenics Pharmaceuticals (PGNX), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), Trevena (TRVN) and AcelRx Pharmaceuticals (ACRX).

(OBSV) raised $98 million in an IPO on Thursday, January 26th 2017. The company issued 6,500,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners acted as the underwriters for the IPO.

Obseva's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (1.45%), Point72 Asset Management L.P. (0.99%), Credit Suisse AG (0.76%), Renaissance Technologies LLC (0.49%), Pictet Asset Management Ltd. (0.33%) and Wedbush Securities Inc. (0.30%).

OBSV stock was sold by a variety of institutional investors in the last quarter, including FMR LLC and Goldman Sachs Group Inc..

OBSV stock was acquired by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Pictet Asset Management Ltd., Renaissance Technologies LLC, Wedbush Securities Inc., Ikarian Capital LLC, Zurcher Kantonalbank Zurich Cantonalbank, Geode Capital Management LLC and Acadian Asset Management LLC.

Shares of OBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OBSV stock can currently be purchased for approximately $3.03.

Obseva has a market capitalization of $137.80 million. The company earns $-76,720,000.00 in net income (profit) each year or ($1.91) on an earnings per share basis. Obseva employs 43 workers across the globe.View Additional Information About Obseva.

The official website for Obseva is http://www.obseva.com/.

Obseva's mailing address is Chemin des Aulx 12 Plan-les-Ouates, Geneva V8, 1228. The company can be reached via phone at 41-22-552-3840 or via email at [email protected]